Abstract
PARK14 patients with homozygous (D331Y) PLA2G6 mutation display motor deficits of pure early-onset Parkinson’s disease (PD). The aim of this study is to investigate the pathogenic mechanism of mutant (D331Y) PLA2G6-induced PD. We generated knockin (KI) mouse model of PARK14 harboring homozygous (D331Y) PLA2G6 mutation. Then, we investigated neuropathological and neurological phenotypes of PLA2G6D331Y/D331Y KI mice and molecular pathogenic mechanisms of (D331Y) PLA2G6-induced degeneration of substantia nigra (SN) dopaminergic neurons. Six-or nine-month-old PLA2G6D331Y/D331Y KI mice displayed early-onset cell death of SNpc dopaminergic neurons. Lewy body pathology was found in the SN of PLA2G6D331Y/D331Y mice. Six-or nine-month-old PLA2G6D331Y/D331Y KI mice exhibited early-onset parkinsonism phenotypes. Disrupted cristae of mitochondria were found in SNpc dopaminergic neurons of PLA2G6D331Y/D331Y mice. PLA2G6D331Y/D331Y mice displayed mitochondrial dysfunction and upregulated ROS production, which may lead to activation of apoptotic cascade. Upregulated protein levels of Grp78, IRE1, PERK, and CHOP, which are involved in activation of ER stress, were found in the SN of PLA2G6D331Y/D331Y mice. Protein expression of mitophagic proteins, including parkin and BNIP3, was downregulated in the SN of PLA2G6D331Y/D331Y mice, suggesting that (D331Y) PLA2G6 mutation causes mitophagy dysfunction. In the SN of PLA2G6D331Y/D331Y mice, mRNA levels of eight genes that are involved in neuroprotection/neurogenesis were decreased, while mRNA levels of two genes that promote apoptotic death were increased. Our results suggest that PARK14 (D331Y) PLA2G6 mutation causes degeneration of SNpc dopaminergic neurons by causing mitochondrial dysfunction, elevated ER stress, mitophagy impairment, and transcriptional abnormality.
Similar content being viewed by others
References
Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, Hardy J, Leverenz JB et al (2009) Neuropathological assessment of Parkinson’s disease: Refining the diagnostic criteria. Lancet Neurol 8(12):1150–1157. https://doi.org/10.1016/S1474-4422(09)70238-8S1474-4422(09)70238-8
Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies. Proc Natl Acad Sci U S A 95(11):6469–6473
Schapira AH, Jenner P (2011) Etiology and pathogenesis of Parkinson’s disease. Mov Disord 26(6):1049–1055. https://doi.org/10.1002/mds.23732
Menzies FM, Fleming A, Caricasole A, Bento CF, Andrews SP, Ashkenazi A, Fullgrabe J, Jackson A et al (2017) Autophagy and neurodegeneration: pathogenic mechanisms and therapeutic opportunities. Neuron 93(5):1015–1034. https://doi.org/10.1016/j.neuron.2017.01.022
Houlden H, Singleton AB (2012) The genetics and neuropathology of Parkinson’s disease. Acta Neuropathol 124(3):325–338. https://doi.org/10.1007/s00401-012-1013-5
Hayflick SJ, Kurian MA, Hogarth P (2018) Neurodegeneration with brain iron accumulation. Handb Clin Neurol 147:293–305. https://doi.org/10.1016/B978-0-444-63233-3.00019-1
Lu CS, SC Lai RMW, Weng YH, Huang CL, Chen RS, Chang HC, Wu-Chou YH, Yeh TH (2012) PLA2G6 mutations in PARK14-linked young-onset parkinsonism and sporadic Parkinson’s disease. Am J Med Genet B Neuropsychiatr Genet 159B(2):183–191. https://doi.org/10.1002/ajmg.b.32012
Shi CH, Tang BS, Wang L, Lv ZY, Wang J, Luo LZ, Shen L, Jiang H et al (2011) PLA2G6 gene mutation in autosomal recessive early-onset parkinsonism in a Chinese cohort. Neurology 77(1):75–81
Xie F, Cen Z, Ouyang Z, Wu S, Xiao J, Luo W (2015) Homozygous p.D331Y mutation in PLA2G6 in two patients with pure autosomal-recessive early-onset parkinsonism: further evidence of a fourth phenotype of PLA2G6-associated neurodegeneration. Parkinsonism Relat Disord 21(4):420–422. https://doi.org/10.1016/j.parkreldis.2015.01.012S1353-8020(15)00032-2
Ramanadham S, Ali T, Ashley JW, Bone RN, Hancock WD, Lei X (2015) Calcium-independent phospholipases A2 and their roles in biological processes and diseases. J Lipid Res 56(9):1643–1668. https://doi.org/10.1194/jlr.R058701jlr.R058701
Ong WY, Farooqui T, Farooqui AA (2010) Involvement of cytosolic phospholipase A(2), calcium independent phospholipase A(2) and plasmalogen selective phospholipase A(2) in neurodegenerative and neuropsychiatric conditions. Curr Med Chem 17(25):2746–2763
Xie Z, MC Gong WS, Turk J, Guo Z (2007) Group VIA phospholipase A2 (iPLA2beta) participates in angiotensin II-induced transcriptional up-regulation of regulator of g-protein signaling-2 in vascular smooth muscle cells. J Biol Chem 282(35):25278–25289. https://doi.org/10.1074/jbc.M611206200
Kinghorn KJ, Castillo-Quan JI, Bartolome F, Angelova PR, Li L, Pope S, Cocheme HM, Khan S et al (2015) Loss of PLA2G6 leads to elevated mitochondrial lipid peroxidation and mitochondrial dysfunction. Brain 138(Pt 7):1801–1816. https://doi.org/10.1093/brain/awv132awv132
Beck G, Sugiura Y, Shinzawa K, Kato S, Setou M, Tsujimoto Y, Sakoda S, Sumi-Akamaru H (2011) Neuroaxonal dystrophy in calcium-independent phospholipase A2beta deficiency results from insufficient remodeling and degeneration of mitochondrial and presynaptic membranes. J Neurosci 31(31):11411–11420. https://doi.org/10.1523/JNEUROSCI.0345-11.201131/31/11411
Zhou Q, Yen A, Rymarczyk G, Asai H, Trengrove C, Aziz N, Kirber MT, Mostoslavsky G et al (2016) Impairment of PARK14-dependent Ca(2+) signalling is a novel determinant of Parkinson’s disease. Nat Commun 7:10332. https://doi.org/10.1038/ncomms10332ncomms10332
Gao L, Hidalgo-Figueroa M, Escudero LM, Diaz-Martin J, Lopez-Barneo J, Pascual A (2013) Age-mediated transcriptomic changes in adult mouse substantia nigra. PLoS One 8(4):e62456. https://doi.org/10.1371/journal.pone.0062456
Masuda-Suzukake M, Nonaka T, Hosokawa M, Oikawa T, Arai T, Akiyama H, Mann DM, Hasegawa M (2013) Prion-like spreading of pathological alpha-synuclein in brain. Brain 136(Pt 4):1128–1138. https://doi.org/10.1093/brain/awt037
Henderson MX, Chung CH, Riddle DM, Zhang B, Gathagan RJ, Seeholzer SH, Trojanowski JQ, Lee VMY (2017) Unbiased proteomics of early Lewy body formation model implicates active microtubule affinity-regulating kinases (MARKs) in synucleinopathies. J Neurosci 37(24):5870–5884. https://doi.org/10.1523/JNEUROSCI.2705-16.2017
Paisan-Ruiz C, Li A, Schneider SA, Holton JL, Johnson R, Kidd D, Chataway J, Bhatia KP et al (2012) Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations. Neurobiol Aging 33(4):814–823. https://doi.org/10.1016/j.neurobiolaging.2010.05.009S0197-4580(10)00223-X
Paisan-Ruiz C, Bhatia KP, Li A, Hernandez D, Davis M, Wood NW, Hardy J, Houlden H et al (2009) Characterization of PLA2G6 as a locus for dystonia-parkinsonism. Ann Neurol 65(1):19–23. https://doi.org/10.1002/ana.21415
Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD (1990) Mitochondrial complex I deficiency in Parkinson’s disease. J Neurochem 54(3):823–827
Kagan VE, Tyurin VA, Jiang J, Tyurina YY, Ritov VB, Amoscato AA, Osipov AN, Belikova NA et al (2005) Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol 1(4):223–232. https://doi.org/10.1038/nchembio727
Remondelli P, Renna M (2017) The endoplasmic reticulum unfolded protein response in neurodegenerative disorders and its potential therapeutic significance. Front Mol Neurosci 10:187. https://doi.org/10.3389/fnmol.2017.00187
Celardo I, Costa AC, Lehmann S, Jones C, Wood N, Mencacci NE, Mallucci GR, Loh SH et al (2016) Mitofusin-mediated ER stress triggers neurodegeneration in pink1/parkin models of Parkinson’s disease. Cell Death Dis 7(6):e2271. https://doi.org/10.1038/cddis.2016.173cddis2016173
Lei X, Zhang S, Bohrer A, Bao S, Song H, Ramanadham S (2007) The group VIA calcium-independent phospholipase A2 participates in ER stress-induced INS-1 insulinoma cell apoptosis by promoting ceramide generation via hydrolysis of sphingomyelins by neutral sphingomyelinase. Biochemistry 46(35):10170–10185. https://doi.org/10.1021/bi700017z
Rodolfo C, Campello S, Cecconi F (2017) Mitophagy in neurodegenerative diseases. Neurochem Int. https://doi.org/10.1016/j.neuint.2017.08.004
Thomas RL, Kubli DA, Gustafsson AB (2011) Bnip3-mediated defects in oxidative phosphorylation promote mitophagy. Autophagy 7(7):775–777
Yu W, Polepalli J, Wagh D, Rajadas J, Malenka R, Lu B (2012) A critical role for the PAR-1/MARK-tau axis in mediating the toxic effects of Abeta on synapses and dendritic spines. Hum Mol Genet 21(6):1384–1390. https://doi.org/10.1093/hmg/ddr576ddr576
Liston P, Fong WG, Kelly NL, Toji S, Miyazaki T, Conte D, Tamai K, Craig CG et al (2001) Identification of XAF1 as an antagonist of XIAP anti-caspase activity. Nat Cell Biol 3(2):128–133. https://doi.org/10.1038/35055027
Kowalczyk A, RK Filipkowski MR, Wilczynski GM, FA Konopacki JJ, Ciemerych MA, Sicinski P, Kaczmarek L (2004) The critical role of cyclin D2 in adult neurogenesis. J Cell Biol 167(2):209–213. https://doi.org/10.1083/jcb.200404181
IM Ethell FI, Kalo MS, Couchman JR, Pasquale EB, Yamaguchi Y (2001) EphB/syndecan-2 signaling in dendritic spine morphogenesis. Neuron 31(6):1001–1013
Cavanaugh JE, Jaumotte JD, Lakoski JM, Zigmond MJ (2006) Neuroprotective role of ERK1/2 and ERK5 in a dopaminergic cell line under basal conditions and in response to oxidative stress. J Neurosci Res 84(6):1367–1375. https://doi.org/10.1002/jnr.21024
Du J, Zhu Y, Chen X, Fei Z, Yang S, Yuan W, Zhang J, Zhu T (2007) Protective effect of bone morphogenetic protein-6 on neurons from H2O2 injury. Brain Res 1163:10–20. https://doi.org/10.1016/j.brainres.2007.06.002
Liu Y, Hao S, Yang B, Fan Y, Qin X, Chen Y, Hu J (2017) Wnt/beta-catenin signaling plays an essential role in alpha7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model. Biochem Pharmacol 140:115–123. https://doi.org/10.1016/j.bcp.2017.05.017
Duffy AM, Schaner MJ, Wu SH, Staniszewski A, Kumar A, Arevalo JC, Arancio O, Chao MV et al (2011) A selective role for ARMS/Kidins220 scaffold protein in spatial memory and trophic support of entorhinal and frontal cortical neurons. Exp Neurol 229(2):409–420. https://doi.org/10.1016/j.expneurol.2011.03.008S0014-4886(11)00091-4
Meyer RC, Giddens MM, Coleman BM, Hall RA (2014) The protective role of prosaposin and its receptors in the nervous system. Brain Res 1585:1–12. https://doi.org/10.1016/j.brainres.2014.08.022S0006-8993(14)01086-5
Park HK, Cho AR, Lee SC, Ban JY (2012) MPTP-induced model of Parkinson’s disease in heat shock protein 70.1 knockout mice. Mol Med Rep 5(6):1465–1468. https://doi.org/10.3892/mmr.2012.839
Yoshino H, Tomiyama H, Tachibana N, Ogaki K, Li Y, Funayama M, Hashimoto T, Takashima S et al (2010) Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism. Neurology 75(15):1356–1361. https://doi.org/10.1212/WNL.0b013e3181f7364975/15/1356
Bonifati V (2014) Genetics of Parkinson’s disease—state of the art, 2013. Parkinsonism Relat Disord 20(Suppl 1):S23–S28. https://doi.org/10.1016/S1353-8020(13)70009-9S1353-8020(13)70009-9
Miki Y, Yoshizawa T, Morohashi S, Seino Y, Kijima H, Shoji M, Mori A, Yamashita C et al (2017) Neuropathology of PARK14 is identical to idiopathic Parkinson’s disease. Mov Disord 32(5):799–800. https://doi.org/10.1002/mds.26952
Beck G, Shinzawa K, Hayakawa H, Baba K, Sumi-Akamaru H, Tsujimoto Y, Mochizuki H (2016) Progressive axonal degeneration of nigrostriatal dopaminergic neurons in calcium-independent phospholipase A2beta knockout mice. PLoS One 11(4):e0153789. https://doi.org/10.1371/journal.pone.0153789
Sumi-Akamaru H, Beck G, Kato S, Mochizuki H (2015) Neuroaxonal dystrophy in PLA2G6 knockout mice. Neuropathology 35(3):289–302. https://doi.org/10.1111/neup.12202
Blanchard H, Taha AY, Cheon Y, Kim HW, Turk J, Rapoport SI (2014) iPLA2beta knockout mouse, a genetic model for progressive human motor disorders, develops age-related neuropathology. Neurochem Res 39(8):1522–1532. https://doi.org/10.1007/s11064-014-1342-y
Sumi-Akamaru H, Beck G, Shinzawa K, Kato S, Riku Y, Yoshida M, Fujimura H, Tsujimoto Y et al (2016) High expression of alpha-synuclein in damaged mitochondria with PLA2G6 dysfunction. Acta Neuropathol Commun 4:27. https://doi.org/10.1186/s40478-016-0298-3
Michel PP, Hirsch EC, Hunot S (2016) Understanding dopaminergic cell death pathways in Parkinson disease. Neuron 90(4):675–691. https://doi.org/10.1016/j.neuron.2016.03.038S0896-6273(16)30058-7
Esteves AR, Arduino DM, Silva DF, Oliveira CR, Cardoso SM (2011) Mitochondrial dysfunction: the road to alpha-synuclein oligomerization in PD. Parkinsons Dis 2011(693761):1–20. https://doi.org/10.4061/2011/693761
Takahashi M, Ko LW, Kulathingal J, Jiang P, Sevlever D, Yen SH (2007) Oxidative stress-induced phosphorylation, degradation and aggregation of alpha-synuclein are linked to upregulated CK2 and cathepsin D. Eur J Neurosci 26(4):863–874. https://doi.org/10.1111/j.1460-9568.2007.05736.x
Mercado G, Castillo V, Vidal R, Hetz C (2015) ER proteostasis disturbances in Parkinson’s disease: novel insights. Front Aging Neurosci 7:39. https://doi.org/10.3389/fnagi.2015.00039
Urra H, Dufey E, Lisbona F, Rojas-Rivera D, Hetz C (2013) When ER stress reaches a dead end. Biochim Biophys Acta 1833(12):3507–3517. https://doi.org/10.1016/j.bbamcr.2013.07.024S0167-4889(13)00311-X
Colla E, Coune P, Liu Y, Pletnikova O, Troncoso JC, Iwatsubo T, Schneider BL, Lee MK (2012) Endoplasmic reticulum stress is important for the manifestations of alpha-synucleinopathy in vivo. J Neurosci 32(10):3306–3320. https://doi.org/10.1523/JNEUROSCI.5367-11.201232/10/3306
Martinez-Vicente M (2017) Neuronal mitophagy in neurodegenerative diseases. Front Mol Neurosci 10:64. https://doi.org/10.3389/fnmol.2017.00064
Crews L, Adame A, Patrick C, Delaney A, Pham E, Rockenstein E, Hansen L, Masliah E (2010) Increased BMP6 levels in the brains of Alzheimer’s disease patients and APP transgenic mice are accompanied by impaired neurogenesis. J Neurosci 30(37):12252–12262. https://doi.org/10.1523/JNEUROSCI.1305-10.201030/37/12252
Jordan J, Bottner M, Schluesener HJ, Unsicker K, Krieglstein K (1997) Bone morphogenetic proteins: neurotrophic roles for midbrain dopaminergic neurons and implications of astroglial cells. Eur J Neurosci 9(8):1699–1709
Garthe A, Huang Z, Kaczmarek L, Filipkowski RK, Kempermann G (2014) Not all water mazes are created equal: cyclin D2 knockout mice with constitutively suppressed adult hippocampal neurogenesis do show specific spatial learning deficits. Genes Brain Behav 13(4):357–364. https://doi.org/10.1111/gbb.12130
Luo SX, Huang EJ (2016) Dopaminergic neurons and brain reward pathways: from neurogenesis to circuit assembly. Am J Pathol 186(3):478–488. https://doi.org/10.1016/j.ajpath.2015.09.023S0002-9440(15)00646-X
Joksimovic M, Awatramani R (2014) Wnt/beta-catenin signaling in midbrain dopaminergic neuron specification and neurogenesis. J Mol Cell Biol 6(1):27–33. https://doi.org/10.1093/jmcb/mjt043mjt043
Neubrand VE, Cesca F, Benfenati F, Schiavo G (2012) Kidins220/ARMS as a functional mediator of multiple receptor signalling pathways. J Cell Sci 125(Pt 8):1845–1854. https://doi.org/10.1242/jcs.102764jcs.102764
Scholz-Starke J, Cesca F, Schiavo G, Benfenati F, Baldelli P (2012) Kidins220/ARMS is a novel modulator of short-term synaptic plasticity in hippocampal GABAergic neurons. PLoS One 7(4):e35785. https://doi.org/10.1371/journal.pone.0035785
Li N, Sarojini H, An J, Wang E (2010) Prosaposin in the secretome of marrow stroma-derived neural progenitor cells protects neural cells from apoptotic death. J Neurochem 112(6):1527–1538. https://doi.org/10.1111/j.1471-4159.2009.06565.xJNC6565
Gao HL, Li C, Nabeka H, Shimokawa T, Saito S, Wang ZY, Cao YM, Matsuda S (2013) Attenuation of MPTP/MPP(+) toxicity in vivo and in vitro by an 18-mer peptide derived from prosaposin. Neuroscience 236:373–393. https://doi.org/10.1016/j.neuroscience.2013.01.007S0306-4522(13)00023-7
Naz F, Anjum F, Islam A, Ahmad F, Hassan MI (2013) Microtubule affinity-regulating kinase 4: structure, function, and regulation. Cell Biochem Biophys 67(2):485–499. https://doi.org/10.1007/s12013-013-9550-7
West T, Stump M, Lodygensky G, Neil JJ, Deshmukh M, Holtzman DM (2009) Lack of X-linked inhibitor of apoptosis protein leads to increased apoptosis and tissue loss following neonatal brain injury. ASN Neuro 1(1):AN20090005. https://doi.org/10.1042/AN20090005e00004
Acknowledgements
The authors are grateful to Microscopy Core Laboratory and Center for Advanced Molecular Imaging and Translation, Department of Nuclear Medicine, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan. We thank Han Chiu and Chia-Chen Hsu for assistance and technical support. We would like to thank Chih-Wei Hu and Wen-Ai Wu of Transgenic Mouse Core Laboratory of Experimental Animal Center for help with ES cells microinjection.
Funding
This work was supported by the Ministry of Science and Technology, Taiwan (MOST 104-2314-B-182A-35-, MOST 105-2314-B-038-092-MY3 and MOST 105-2314-B-182A-013-MY3 to TH Yeh; MOST 105-2314-B-182A-003- and MOST 106-2314-B-182A-012-MY3 to CC Chiu; MOST104-2320-B-182-014-MY3 to HL Wang), Taipei Medical University (TMU106-AE1-B20 to TH Yeh), and the Chang Gung Medical Foundation (grants CMRPG3C1482, CMRPG3C0783, CMRPG3C1491, CMRPG3C1492, CMRPG3D0382, CRRPG3C0023, CRRPG3C0033 to TH Yeh.; CMRPG3F1821 to CC Chiu; CMRPD1B0332, CMRPD1C0623, CRRPD1C0013, CMRPD180433, and EMRPD1F0251 to HL Wang).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Animal experiments were performed in accordance with protocols approved by Institutional Animal Care and Use Committee (IACUC) of Chang Gung University.
Conflict of Interest
The authors declare that they have no competing financial interests.
Rights and permissions
About this article
Cite this article
Chiu, CC., Lu, CS., Weng, YH. et al. PARK14 (D331Y) PLA2G6 Causes Early-Onset Degeneration of Substantia Nigra Dopaminergic Neurons by Inducing Mitochondrial Dysfunction, ER Stress, Mitophagy Impairment and Transcriptional Dysregulation in a Knockin Mouse Model. Mol Neurobiol 56, 3835–3853 (2019). https://doi.org/10.1007/s12035-018-1118-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-018-1118-5